⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure 1 from Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer

Francesco Facchinetti Antoine Hollebecque Floriane Brayé Damien Vasseur Yoann Pradat Rastislav Bahleda Cédric Pobel Ludovic Bigot Olivier Déas Juan David Florez Arango Giorgia Guaitoli Hayato Mizuta David Combarel Lambros Tselikas Stefan Michiels Sergey I. Nikolaev Jean‐Yves Scoazec Santiago Ponce-Aix Benjamin Besse Ken A. Olaussen Yohann Loriot Luc Friboulet

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

RNAseq analysis from tissue biopsies of 39 advanced urothelial cancers.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Facchinetti et al. (2024) studied this question.

synapsesocial.com/papers/68e587eeb6db643587523d48 https://doi.org/10.1158/2159-8290.27025955

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 1 from Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer2024
2Supplementary Figure 1 from Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer2024
3Supplementary Figure 1 from Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer2024
4Supplementary Figure 3 from Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer2024
5Supplementary Figure 3 from Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer2024

More related papers

Supplementary Figure 2 from Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer2024
Supplementary Figure 2 from Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer2024
Supplementary Figure 2 from Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer2024